Recent Deal

London Technology Fund Invests in Acrobot

London Technology Fund (LTF), London’s specialist investor in new technology companies, today announced it has completed an investment in Acrobot, a company focusing on computer assistance for orthopaedic surgery. LTF is part of a syndicate investing up to £2.6m.

The syndicate includes PUK Ventures and Imperial Innovations Group plc and was co-led by LTF and PUK Ventures. Following the investment an experienced finance director will be appointed and the company will move to new premises.
Acrobot has developed and clinically proven a range of products in three key areas related to orthopaedic surgery: computer-assisted 3D planning, surgical navigation and surgeon-controlled robotic surgery. The company is now poised to move forward to full commercialisation of its Planner and Navigation solutions and will further develop its key ‘active constraint’ technology for robotic applications. Its unique surgical navigation system tracks the position of surgical instruments relative to the patent to ensure highly accurate surgery – enabling bone preparation and implant positioning exactly in line with the preoperative plan created using Acrobot® Planner.

Commenting on the fundraising, Graeme Brookes, CEO of Acrobot, said: “LTF’s understanding of fast growing high technology companies and their rigorous approach to due diligence played an essential part in our fundraising. We now have the resources necessary to take out exciting developments to market and to further develop key next generation robotic too9ls that engage the orthopaedic surgeon and offer reproducibility coupled with improved ease of use”.

David McMeekin, Chairman of the London Technology Fund, said: “We are delighted to be able to support the founders and management team of Acrobot, as they develop these existing systems to assist orthopaedic surgeons.”

Marriott Harrison acted for the London Technology Fund.